Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 118 entries
Sorted by: Best Match Show Resources per page
Quality of Life and Sexual Health in the Aging of PCa Survivors.

International journal of endocrinology

Gacci M, Baldi E, Tamburrino L, Detti B, Livi L, De Nunzio C, Tubaro A, Gravas S, Carini M, Serni S.
PMID: 24744780
Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17.

Prostate cancer (PCa) is the most common malignancy in elderly men. The progressive ageing of the world male population will further increase the need for tailored assessment and treatment of PCa patients. The determinant role of androgens and sexual...

Cite
Gacci M, Baldi E, Tamburrino L, et al. Quality of Life and Sexual Health in the Aging of PCa Survivors. Int J Endocrinol. 2014;2014:470592doi: 10.1155/2014/470592.
Gacci, M., Baldi, E., Tamburrino, L., Detti, B., Livi, L., De Nunzio, C., Tubaro, A., Gravas, S., Carini, M., & Serni, S. (2014). Quality of Life and Sexual Health in the Aging of PCa Survivors. International journal of endocrinology, 2014470592. https://doi.org/10.1155/2014/470592
Gacci, Mauro, et al. "Quality of Life and Sexual Health in the Aging of PCa Survivors." International journal of endocrinology vol. 2014 (2014): 470592. doi: https://doi.org/10.1155/2014/470592
Gacci M, Baldi E, Tamburrino L, Detti B, Livi L, De Nunzio C, Tubaro A, Gravas S, Carini M, Serni S. Quality of Life and Sexual Health in the Aging of PCa Survivors. Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17. PMID: 24744780; PMCID: PMC3976934.
Copy Download .nbib Format: NLM
MLC1 protein: a likely link between leukodystrophies and brain channelopathies.

Frontiers in cellular neuroscience

Brignone MS, Lanciotti A, Camerini S, De Nuccio C, Petrucci TC, Visentin S, Ambrosini E.
PMID: 25883547
Front Cell Neurosci. 2015 Apr 01;9:66. doi: 10.3389/fncel.2015.00106. eCollection 2015.

Megalencephalic leukoencephalopathy with subcortical cysts (MLCs) disease is a rare inherited, autosomal recessive form of childhood-onset spongiform leukodystrophy characterized by macrocephaly, deterioration of motor functions, epileptic seizures and mental decline. Brain edema, subcortical fluid cysts, myelin and astrocyte vacuolation...

Cite
Brignone MS, Lanciotti A, Camerini S, et al. MLC1 protein: a likely link between leukodystrophies and brain channelopathies. Front Cell Neurosci. 2015;9:66doi: 10.3389/fncel.2015.00106.
Brignone, M. S., Lanciotti, A., Camerini, S., De Nuccio, C., Petrucci, T. C., Visentin, S., & Ambrosini, E. (2015). MLC1 protein: a likely link between leukodystrophies and brain channelopathies. Frontiers in cellular neuroscience, 966. https://doi.org/10.3389/fncel.2015.00106
Brignone, Maria S, et al. "MLC1 protein: a likely link between leukodystrophies and brain channelopathies." Frontiers in cellular neuroscience vol. 9 (2015): 66. doi: https://doi.org/10.3389/fncel.2015.00106
Brignone MS, Lanciotti A, Camerini S, De Nuccio C, Petrucci TC, Visentin S, Ambrosini E. MLC1 protein: a likely link between leukodystrophies and brain channelopathies. Front Cell Neurosci. 2015 Apr 01;9:66. doi: 10.3389/fncel.2015.00106. eCollection 2015. PMID: 25883547; PMCID: PMC4381631.
Copy Download .nbib Format: NLM
Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors.

Genes & nutrition

Bordoni A, Di Nunzio M, Danesi F, Biagi PL.
PMID: 18850203
Genes Nutr. 2006 Jun;1(2):95-106. doi: 10.1007/BF02829951.

Dietary polyunsaturated fatty acids (PUFAs) function not only by altering membrane lipid composition, cellular metabolism, signal transduction, but possess also effects on gene expression by regulating the activity/abundance of different nuclear transcription factors: peroxisome proliferator activated receptors, retinoid X...

Cite
Bordoni A, Di Nunzio M, Danesi F, et al. Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors. Genes Nutr. 2006;1(2):95-106doi: 10.1007/BF02829951.
Bordoni, A., Di Nunzio, M., Danesi, F., & Biagi, P. L. (2006). Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors. Genes & nutrition, 1(2), 95-106. https://doi.org/10.1007/BF02829951
Bordoni, A, et al. "Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors." Genes & nutrition vol. 1,2 (2006): 95-106. doi: https://doi.org/10.1007/BF02829951
Bordoni A, Di Nunzio M, Danesi F, Biagi PL. Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors. Genes Nutr. 2006 Jun;1(2):95-106. doi: 10.1007/BF02829951. PMID: 18850203; PMCID: PMC3454679.
Copy Download .nbib Format: NLM
Effect of once-daily alfuzosin on urinary symptoms and flow rate in benign prostatic hyperplasia : a 24-hour home-uroflowmetry evaluation.

Clinical drug investigation

De Nunzio C, Franco G, Leonardo C, Trucchi A, Tubaro A, Laurenti C.
PMID: 17532676
Clin Drug Investig. 2005;25(6):359-65. doi: 10.2165/00044011-200525060-00001.

OBJECTIVE: To analyse the clinical and 24-hour urinary flow efficacy of alfuzosin 10mg once daily (OD), by means of the International Prostate Symptom Score (I-PSS) and home-based uroflowmetry (P-Flow) measurement, in patients with lower urinary tract symptoms (LUTS) related...

Cite
De Nunzio C, Franco G, Leonardo C, et al. Effect of once-daily alfuzosin on urinary symptoms and flow rate in benign prostatic hyperplasia : a 24-hour home-uroflowmetry evaluation. Clin Drug Investig. 2005;25(6):359-65doi: 10.2165/00044011-200525060-00001.
De Nunzio, C., Franco, G., Leonardo, C., Trucchi, A., Tubaro, A., & Laurenti, C. (2005). Effect of once-daily alfuzosin on urinary symptoms and flow rate in benign prostatic hyperplasia : a 24-hour home-uroflowmetry evaluation. Clinical drug investigation, 25(6), 359-65. https://doi.org/10.2165/00044011-200525060-00001
De Nunzio, Cosimo, et al. "Effect of once-daily alfuzosin on urinary symptoms and flow rate in benign prostatic hyperplasia : a 24-hour home-uroflowmetry evaluation." Clinical drug investigation vol. 25,6 (2005): 359-65. doi: https://doi.org/10.2165/00044011-200525060-00001
De Nunzio C, Franco G, Leonardo C, Trucchi A, Tubaro A, Laurenti C. Effect of once-daily alfuzosin on urinary symptoms and flow rate in benign prostatic hyperplasia : a 24-hour home-uroflowmetry evaluation. Clin Drug Investig. 2005;25(6):359-65. doi: 10.2165/00044011-200525060-00001. PMID: 17532676.
Copy Download .nbib Format: NLM
Deposition of SiO2 films with high laser damage thresholds by ion-assisted electron-beam evaporation.

Applied optics

Alvisi M, De Nunzio G, Di Giulio M, Ferrara MC, Perrone MR, Protopapa L, Vasanelli L.
PMID: 18305738
Appl Opt. 1999 Mar 01;38(7):1237-43. doi: 10.1364/ao.38.001237.

SiO(2) thin films (approximately 100 nm thick) with transmittivity and a laser damage threshold nearly equal to those of bulk material are deposited on silica substrates by the technique of ion-assisted electron-beam evaporation. The influence of film packing density...

Cite
Alvisi M, De Nunzio G, Di Giulio M, et al. Deposition of SiO2 films with high laser damage thresholds by ion-assisted electron-beam evaporation. Appl Opt. 1999;38(7):1237-43doi: 10.1364/ao.38.001237.
Alvisi, M., De Nunzio, G., Di Giulio, M., Ferrara, M. C., Perrone, M. R., Protopapa, L., & Vasanelli, L. (1999). Deposition of SiO2 films with high laser damage thresholds by ion-assisted electron-beam evaporation. Applied optics, 38(7), 1237-43. https://doi.org/10.1364/ao.38.001237
Alvisi, M, et al. "Deposition of SiO2 films with high laser damage thresholds by ion-assisted electron-beam evaporation." Applied optics vol. 38,7 (1999): 1237-43. doi: https://doi.org/10.1364/ao.38.001237
Alvisi M, De Nunzio G, Di Giulio M, Ferrara MC, Perrone MR, Protopapa L, Vasanelli L. Deposition of SiO2 films with high laser damage thresholds by ion-assisted electron-beam evaporation. Appl Opt. 1999 Mar 01;38(7):1237-43. doi: 10.1364/ao.38.001237. PMID: 18305738.
Copy Download .nbib Format: NLM
Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network.

Molecular and clinical oncology

Pizzi C, Arpino G, Acampora G, Aiello N, DE Rosa A, Diaferia I, DI Nunzio A, Fragna G, Franco A, Russo M, Sansone F, Scarpati C, Spinuso A, Arpino G, Luce A, Tommasielli G, Caraglia M, DE Placido S.
PMID: 24649236
Mol Clin Oncol. 2013 Jul;1(4):726-732. doi: 10.3892/mco.2013.101. Epub 2013 Apr 04.

The Italian cancer registries network has not been sufficiently developed in the Southern regions. General practitioners (GPs) are knowledgeable about the prevalence, incidence and mortality for different types of cancer in their patient populations. The aim of this pilot...

Cite
Pizzi C, Arpino G, Acampora G, et al. Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network. Mol Clin Oncol. 2013;1(4):726-732doi: 10.3892/mco.2013.101.
Pizzi, C., Arpino, G., Acampora, G., Aiello, N., DE Rosa, A., Diaferia, I., DI Nunzio, A., Fragna, G., Franco, A., Russo, M., Sansone, F., Scarpati, C., Spinuso, A., Arpino, G., Luce, A., Tommasielli, G., Caraglia, M., & DE Placido, S. (2013). Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network. Molecular and clinical oncology, 1(4), 726-732. https://doi.org/10.3892/mco.2013.101
Pizzi, Claudia, et al. "Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network." Molecular and clinical oncology vol. 1,4 (2013): 726-732. doi: https://doi.org/10.3892/mco.2013.101
Pizzi C, Arpino G, Acampora G, Aiello N, DE Rosa A, Diaferia I, DI Nunzio A, Fragna G, Franco A, Russo M, Sansone F, Scarpati C, Spinuso A, Arpino G, Luce A, Tommasielli G, Caraglia M, DE Placido S. Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network. Mol Clin Oncol. 2013 Jul;1(4):726-732. doi: 10.3892/mco.2013.101. Epub 2013 Apr 04. PMID: 24649236; PMCID: PMC3915682.
Copy Download .nbib Format: NLM
Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells.

Oncotarget

Pascucci B, D'Errico M, Romagnoli A, De Nuccio C, Savino M, Pietraforte D, Lanzafame M, Calcagnile AS, Fortini P, Baccarini S, Orioli D, Degan P, Visentin S, Stefanini M, Isidoro C, Fimia GM, Dogliotti E.
PMID: 29262528
Oncotarget. 2016 Jun 07;8(61):102852-102867. doi: 10.18632/oncotarget.9913. eCollection 2017 Nov 28.

The ERCC8/CSA gene encodes a WD-40 repeat protein (CSA) that is part of a E3-ubiquitin ligase/COP9 signalosome complex. When mutated, CSA causes the Cockayne Syndrome group A (CS-A), a rare recessive progeroid disorder characterized by sun sensitivity and neurodevelopmental...

Cite
Pascucci B, D'Errico M, Romagnoli A, et al. Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells. Oncotarget. 2016;8(61):102852-102867doi: 10.18632/oncotarget.9913.
Pascucci, B., D'Errico, M., Romagnoli, A., De Nuccio, C., Savino, M., Pietraforte, D., Lanzafame, M., Calcagnile, A. S., Fortini, P., Baccarini, S., Orioli, D., Degan, P., Visentin, S., Stefanini, M., Isidoro, C., Fimia, G. M., & Dogliotti, E. (2017). Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells. Oncotarget, 8(61), 102852-102867. https://doi.org/10.18632/oncotarget.9913
Pascucci, Barbara, et al. "Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells." Oncotarget vol. 8,61 (2017): 102852-102867. doi: https://doi.org/10.18632/oncotarget.9913
Pascucci B, D'Errico M, Romagnoli A, De Nuccio C, Savino M, Pietraforte D, Lanzafame M, Calcagnile AS, Fortini P, Baccarini S, Orioli D, Degan P, Visentin S, Stefanini M, Isidoro C, Fimia GM, Dogliotti E. Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells. Oncotarget. 2016 Jun 07;8(61):102852-102867. doi: 10.18632/oncotarget.9913. eCollection 2017 Nov 28. PMID: 29262528; PMCID: PMC5732694.
Copy Download .nbib Format: NLM
Castration-resistance prostate cancer: what is in the pipeline?.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology

DE Nunzio C, Presicce F, Giacinti S, Bassanelli M, Tubaro A.
PMID: 28707844
Minerva Urol Nefrol. 2018 Feb;70(1):22-41. doi: 10.23736/S0393-2249.17.02976-9. Epub 2017 Jul 12.

INTRODUCTION: To evaluate the available evidence on the standard diagnosis and management of men with metastatic castration resistant prostate cancer (mCRPC), and providing the timely update on new pharmacological treatments.EVIDENCE ACQUISITION: A systematic literature search from from January 2000...

Cite
DE Nunzio C, Presicce F, Giacinti S, et al. Castration-resistance prostate cancer: what is in the pipeline?. Minerva Urol Nefrol. 2017;70(1):22-41doi: 10.23736/S0393-2249.17.02976-9.
DE Nunzio, C., Presicce, F., Giacinti, S., Bassanelli, M., & Tubaro, A. (2018). Castration-resistance prostate cancer: what is in the pipeline?. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 70(1), 22-41. https://doi.org/10.23736/S0393-2249.17.02976-9
DE Nunzio, Cosimo, et al. "Castration-resistance prostate cancer: what is in the pipeline?." Minerva urologica e nefrologica = The Italian journal of urology and nephrology vol. 70,1 (2018): 22-41. doi: https://doi.org/10.23736/S0393-2249.17.02976-9
DE Nunzio C, Presicce F, Giacinti S, Bassanelli M, Tubaro A. Castration-resistance prostate cancer: what is in the pipeline?. Minerva Urol Nefrol. 2018 Feb;70(1):22-41. doi: 10.23736/S0393-2249.17.02976-9. Epub 2017 Jul 12. PMID: 28707844.
Copy Download .nbib Format: NLM
Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status.

Oncology letters

Cavanna L, Seghini P, Di Nunzio C, Orlandi E, Michieletti E, Stroppa EM, Mordenti P, Citterio C, Vecchia S, Zangrandi A.
PMID: 29552209
Oncol Lett. 2018 Apr;15(4):5787-5791. doi: 10.3892/ol.2018.8054. Epub 2018 Feb 14.

Central nervous system (CNS) metastases from cancers of the gastrointestinal tract (GIT) are rare, and occur in 0.16-0.69% of patients with gastric or gastro-esophageal (GE) junction cancer. Overexpression of the human epidermal growth factor 2 (HER-2) is associated with...

Cite
Cavanna L, Seghini P, Di Nunzio C, et al. Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status. Oncol Lett. 2018;15(4):5787-5791doi: 10.3892/ol.2018.8054.
Cavanna, L., Seghini, P., Di Nunzio, C., Orlandi, E., Michieletti, E., Stroppa, E. M., Mordenti, P., Citterio, C., Vecchia, S., & Zangrandi, A. (2018). Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status. Oncology letters, 15(4), 5787-5791. https://doi.org/10.3892/ol.2018.8054
Cavanna, Luigi, et al. "Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status." Oncology letters vol. 15,4 (2018): 5787-5791. doi: https://doi.org/10.3892/ol.2018.8054
Cavanna L, Seghini P, Di Nunzio C, Orlandi E, Michieletti E, Stroppa EM, Mordenti P, Citterio C, Vecchia S, Zangrandi A. Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status. Oncol Lett. 2018 Apr;15(4):5787-5791. doi: 10.3892/ol.2018.8054. Epub 2018 Feb 14. PMID: 29552209; PMCID: PMC5840578.
Copy Download .nbib Format: NLM
Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia.

Oncotarget

De Nunzio C, Giglio S, Stoppacciaro A, Gacci M, Cirombella R, Luciani E, Tubaro A, Vecchione A.
PMID: 28881614
Oncotarget. 2017 Feb 07;8(31):50904-50910. doi: 10.18632/oncotarget.15144. eCollection 2017 Aug 01.

Autophagy is a conserved evolutionary process that allows cells to maintain macromolecular synthesis and energy homeostasis during starvation and stressful conditions. We prospectively evaluated the relationship between autophagy and prostatic inflammation in a series of transurethral prostatic resection samples....

Cite
De Nunzio C, Giglio S, Stoppacciaro A, et al. Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Oncotarget. 2017;8(31):50904-50910doi: 10.18632/oncotarget.15144.
De Nunzio, C., Giglio, S., Stoppacciaro, A., Gacci, M., Cirombella, R., Luciani, E., Tubaro, A., & Vecchione, A. (2017). Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Oncotarget, 8(31), 50904-50910. https://doi.org/10.18632/oncotarget.15144
De Nunzio, Cosimo, et al. "Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia." Oncotarget vol. 8,31 (2017): 50904-50910. doi: https://doi.org/10.18632/oncotarget.15144
De Nunzio C, Giglio S, Stoppacciaro A, Gacci M, Cirombella R, Luciani E, Tubaro A, Vecchione A. Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Oncotarget. 2017 Feb 07;8(31):50904-50910. doi: 10.18632/oncotarget.15144. eCollection 2017 Aug 01. PMID: 28881614; PMCID: PMC5584215.
Copy Download .nbib Format: NLM
Ultrasound-guided Central Venous Catheterization for Home Parenteral Nutrition and Hydratation in Advanced Incurable Cancer Patients: Results of A Prospective Observational Study.

World journal of oncology

Cavanna L, Cordani MR, Biasini C, Di Nunzio C, Monfredo M, Stroppa E, Muroni M, Ambroggi M, Muroni L, Di Cicilia R, Cremona G, Nobili E, Zaffignani E, Civardi G.
PMID: 29147254
World J Oncol. 2011 Oct;2(5):238-244. doi: 10.4021/wjon390e. Epub 2011 Oct 28.

BACKGROUND: Most patients with advanced cancer are frequently malnourished and frequently they develop decreased oral fluid intake and dehidratation. Home parenteral nutrition (HPN) is an increasingly used therapy for patients with advanced cancer. A central venous access device is...

Cite
Cavanna L, Cordani MR, Biasini C, et al. Ultrasound-guided Central Venous Catheterization for Home Parenteral Nutrition and Hydratation in Advanced Incurable Cancer Patients: Results of A Prospective Observational Study. World J Oncol. 2011;2(5):238-244doi: 10.4021/wjon390e.
Cavanna, L., Cordani, M. R., Biasini, C., Di Nunzio, C., Monfredo, M., Stroppa, E., Muroni, M., Ambroggi, M., Muroni, L., Di Cicilia, R., Cremona, G., Nobili, E., Zaffignani, E., & Civardi, G. (2011). Ultrasound-guided Central Venous Catheterization for Home Parenteral Nutrition and Hydratation in Advanced Incurable Cancer Patients: Results of A Prospective Observational Study. World journal of oncology, 2(5), 238-244. https://doi.org/10.4021/wjon390e
Cavanna, Luigi, et al. "Ultrasound-guided Central Venous Catheterization for Home Parenteral Nutrition and Hydratation in Advanced Incurable Cancer Patients: Results of A Prospective Observational Study." World journal of oncology vol. 2,5 (2011): 238-244. doi: https://doi.org/10.4021/wjon390e
Cavanna L, Cordani MR, Biasini C, Di Nunzio C, Monfredo M, Stroppa E, Muroni M, Ambroggi M, Muroni L, Di Cicilia R, Cremona G, Nobili E, Zaffignani E, Civardi G. Ultrasound-guided Central Venous Catheterization for Home Parenteral Nutrition and Hydratation in Advanced Incurable Cancer Patients: Results of A Prospective Observational Study. World J Oncol. 2011 Oct;2(5):238-244. doi: 10.4021/wjon390e. Epub 2011 Oct 28. PMID: 29147254; PMCID: PMC5649685.
Copy Download .nbib Format: NLM
Did Giovanni dalle Bande Nere become a legendary condottiero because of his MAOA gene?.

Journal of affective disorders

Pellegrini S, Mariotti V, Di Nunzio C, Palumbo S, Ricci P, Fornaciari G, Pietrini P.
PMID: 31446383
J Affect Disord. 2019 Dec 01;259:218-220. doi: 10.1016/j.jad.2019.08.038. Epub 2019 Aug 19.

No abstract available.

Cite
Pellegrini S, Mariotti V, Di Nunzio C, et al. Did Giovanni dalle Bande Nere become a legendary condottiero because of his MAOA gene?. J Affect Disord. 2019;259:218-220doi: 10.1016/j.jad.2019.08.038.
Pellegrini, S., Mariotti, V., Di Nunzio, C., Palumbo, S., Ricci, P., Fornaciari, G., & Pietrini, P. (2019). Did Giovanni dalle Bande Nere become a legendary condottiero because of his MAOA gene?. Journal of affective disorders, 259218-220. https://doi.org/10.1016/j.jad.2019.08.038
Pellegrini, S, et al. "Did Giovanni dalle Bande Nere become a legendary condottiero because of his MAOA gene?." Journal of affective disorders vol. 259 (2019): 218-220. doi: https://doi.org/10.1016/j.jad.2019.08.038
Pellegrini S, Mariotti V, Di Nunzio C, Palumbo S, Ricci P, Fornaciari G, Pietrini P. Did Giovanni dalle Bande Nere become a legendary condottiero because of his MAOA gene?. J Affect Disord. 2019 Dec 01;259:218-220. doi: 10.1016/j.jad.2019.08.038. Epub 2019 Aug 19. PMID: 31446383.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 118 entries